Cortical circuitry dysfunction in schizophrenia has been studied at many different levels of resolution, but not at the most basic unit of network organization-synaptic inputs. Multi-label electron or confocal light microscopy is required to examine specific types of synaptic inputs, and application of these methods to quantitatively study disease-related changes in human postmortem tissue has not been feasible for technical reasons. We recently developed a multi-label confocal light microscopic approach that makes possible the systematic identification and quantification of synaptic inputs, and of the relative levels of proteins localized to these inputs, in human postmortem tissue. We applied this approach to quantify parvalbumin basket cell (PVBC) inputs in area 9 of the dorsolateral prefrontal cortex from schizophrenia and matched comparison subjects. Tissue sections were triple-labeled for the 65 kD isoform of glutamic acid decarboxylase (GAD65), PV and the GABA A receptor a1 subunit. PVBC axonal boutons were defined as PV/GAD65 dual-labeled puncta, and PVBC inputs were defined as a PVBC bouton that overlapped a GABA A receptor a1 subunit punctum. The density of PVBC inputs was unchanged in subjects with schizophrenia, but levels of PV protein were lower in PVBC boutons. In concert with prior reports, these findings indicate that PVBC dysfunction in schizophrenia reflects molecular and not structural alterations in these cells and their axon terminals.
Schizophrenia is a complex disorder lacking an effective treatment option for the pervasive and debilitating cognitive impairments experienced by patients. 1 Working memory, a core cognitive process impaired in schizophrenia, depends upon proper activation of circuitry in the dorsolateral prefrontal cortex (DLPFC). 2, 3 One cortical process thought to be essential for working memory is fast, synchronized neuronal activity in the gamma frequency (30-80 Hz). [4] [5] [6] Accordingly, individuals diagnosed with schizophrenia show altered DLPFC activation during tasks that involve working memory, 7 including lower power of prefrontal gamma oscillations. 8, 9 Gamma oscillations require the strong, synchronous inhibition of excitatory pyramidal cells by parvalbumin basket cells (PVBCs). 10 PVBCs robustly innervate the soma and proximal dendrites and spines of pyramidal cells, 11 and their activity is strongly coupled to the gamma rhythm. [12] [13] [14] Indeed, increasing excitation of PV neurons induces gamma oscillations, 15, 16 whereas decreasing excitatory drive to PV neurons impairs gamma oscillations and working memory performance in mice. 17 Unlike PVBCs, PV chandelier cells likely do not participate in gamma oscillation generation. 12, 18, 19 Thus, alterations specifically within PVBC connectivity could underlie impaired gamma oscillations and working memory performance in schizophrenia subjects.
A number of deficits in PV neurons have been identified in the DLPFC of subjects with schizophrenia (reviewed in Lewis et al. 20 ). In layers 3-4, the primary location of PV neurons, 21 PV mRNA is B30% lower, 22 and the density of PV-immunoreactive puncta (small structures that could include the axon terminals of PVBC or thalamic projections) is B20% lower in schizophrenia subjects. 23 Notably, these deficits are not accompanied by a change in PV neuron density, as both mRNA and protein studies have shown no difference in the density of DLPFC PV-positive neurons between healthy comparison and schizophrenia subjects. 22, 24, 25 GABA synthesis also appears to be altered in PV neurons. Expression of mRNA for the 67 kD isoform of glutamic acid decarboxylase (GAD67), one of two GABA synthesizing enzymes, is undetectable in B50% of PV neurons 22 in subjects with schizophrenia, and GAD67 protein levels are B50% lower in PV-immunoreactive axon terminals. 26 Synapses formed by PVBCs are particularly enriched with GABA A receptors that contain a1 subunits, 27, 28 and some, but not all, 29 postmortem studies have demonstrated lower GABA A receptor a1 subunit mRNA expression in the DLPFC at the tissue, laminar and cellular levels. [30] [31] [32] [33] [34] For example, GABA A receptor a1 subunit mRNA expression is B40% lower in layer deep 3 pyramidal cells. 31 Together these results suggest that in schizophrenia both the pre-and postsynaptic components of PVBC inputs to pyramidal neurons are affected such that the density and/or strength of PVBC inputs to pyramidal cells is decreased in DLPFC layer deep 3.
To test this hypothesis, we used a recently developed approach measure to exclude the confounding effects of lipofuscin autofluorescence in human neocortex; (3) systematic sampling and spinning disk confocal microscopy imaging; (4) custom threshold/morphological segmentation algorithms; and (5) the three-dimensional relationship between each label. This approach permits, for the first time, quantitative assessments of the integrity of a specific type of neuronal connection in schizophrenia.
MATERIALS AND METHODS Subjects
Brain specimens from 20 subjects were recovered during autopsies conducted at the Allegheny County Medical Examiner's Office (Pittsburgh, PA, USA) after obtaining consent from the next of kin. An independent committee of experienced research clinicians made consensus DSM-IV diagnoses for each subject using the results of structured interviews conducted with family members and review of medical records, as previously described. 22, 26 To control experimental variance and reduce biological variance between groups, each schizophrenia subject (n ¼ 10) was matched for sex (seven men and three women), and as closely as possible for age, with one healthy comparison subject. Healthy comparison and schizophrenia subject mean ± s. frontal gyrus were sectioned coronally at 40 mm on a cryostat and stored in antifreeze solution at À 30 1C until processing for immunohistochemistry. Three sections per subject, each spaced B400 mm apart, were used. One section from each subject of a pair were processed together to minimize experimental variance within or across subject pairs. Sections were incubated for 48 h in the following primary antibodies: rabbit anti-PV (1:750, Swant, Bellinzona, Switzerland), goat anti-GAD65 (1:50, R&D Systems, Minneapolis, MN, USA) and mouse anti-GABA A receptor a1 subunit (1:200, Millipore, Billerica, MA, USA). The specificity of the mouse anti-GABA A receptor a1 subunit has been previously described. 36 The specificity of the goat anti-GAD65 has been shown by immunoblot in our laboratory (data not shown) and described in the R&D Systems data sheet. The specificity of the rabbit anti-PV antibody has been previously described. 37 Sections were then incubated for 24 h in secondary antibodies (donkey) conjugated to Alexa 488, 568 and 647 (1:500, Invitrogen, Grand Island, NY, USA). The final channel assignment was GABA A receptor a1 subunit (Alexa 488), PV (Alexa 568) and GAD65 (Alexa 647). After washing, sections were mounted (Vecatshield mounting media for fluorescence), coded to obscure diagnosis and subject number, and stored at 4 1C until imaging.
Microscopy and sampling
Image stacks (768 Â 768 pixels; 0.25 mm Z-step) were collected on an Olympus IX71 inverted microscope (Center Valley, PA, USA) equipped with an Olympus DSU spinning disk, using a 60XSC 1.42 N.A. oil immersion objective. The spinning disk confocal microscope was equipped with a Hamamatsu 1394 ORCA camera (Bridgewater, NJ, USA) and high precision BioPrecision2 motorized stage with linear XYZ encoders (Ludl Electronic Products, Hawthorne, NY, USA), and controlled by SlideBook 5.0 (Intelligent Imaging Innovations, Denver, CO, USA), the same software used for postprocessing. TetraSpeck 0.1 mm microspheres (fluorescent blue/green/ orange/dark red; Invitrogen) were used to confirm the absence of alignment issues between wavelengths.
All imaging occurred in layer deep 3 (where PVBCs are predominately located), defined as extending between 35 and 50% of the distance from the pial surface to the layer 6-white matter border, and was performed by one person who was blind to subject diagnosis. Sites were systematically and randomly sampled using a 200 Â 200 mm sampling grid. Running means using pilot data indicated that 10 sites per section were sufficient to adequately sample the region; thus, we collected image stacks from 15 sites within layer deep 3 of each section. Channel exposure times were optimized such that no pixels were saturated and the dynamic range of the camera was filled. The top 1/3 of each tissue section was imaged.
A potential confound of quantitative fluorescence measures in human cortex is lipofuscin autofluorescence. 38 To exclude this potential confound, lipofuscin was imaged using a fourth channel (equivalent to Alexa 405) at a constant exposure time across all sections. Lipofuscin autofluorescence was masked by one person blind to subject diagnosis, using a single optimal threshold value for each image stack. All PV, GAD65 and GABA A receptor a1 subunit masks that overlapped a lipofuscin mask, or contained fluorescent signal in the 405 channelX115 arbitrary units (a.u.), were eliminated from the analysis (Figure 1 ).
Image processing
Image stacks were normalized for exposure time in each channel, cropped to 39 Â 39 mm and the top 10% of Z-planes were eliminated because of the irregularities in the tissue surface associated with cryostat-cut sections. Thus, on average, 53 ± 7 Z-planes for each sampling site were analyzed. Image Z-stacks were then deconvolved using the AutoQuant adaptive blind deconvolution algorithm to improve the clarity of the data by improving resolving power, removing out-of-focus haze and eliminating noise.
A custom threshold/morphological segmentation algorithm was used to create object masks of immunoreactive puncta, identified as small (0.03-0.7 mm 3 ), distinct fluorescing objects, representing labeled pre-or postsynaptic structures. This segmentation algorithm used the RidlerCalvard iterative thresholding method 39 to obtain an initial value for iterative segmentation. The Ridler-Calvard method chooses an initial threshold based on the assumption that the histogram for each channel is the sum of the distributions for both signal and background pixels, and then iteratively calculates a new threshold by taking the mean of the average intensities of the signal and background pixels determined by the initial threshold. This process is repeated until the threshold converges. For optimal masking of pre-and postsynaptic structures, 100 iterations with subsequent threshold settings increasing by 50 gray levels were performed.
Definitions of synaptic structures
Mask operations in SlideBook were used to identify PVBC inputs. Labeling for GAD65, which is preferentially targeted to boutons, 40 was used to classify immunoreactive puncta as GABAergic boutons. A PV-GABAergic bouton was defined as a PV object mask that contained the center of a GAD65 object mask, and a PVBC input was defined as a PV-GABAergic bouton that overlapped a GABA A receptor a1 subunit object mask (Figure 2) . Importantly, glutamatergic PV axonal boutons from the thalamus were excluded by using GAD65 to identify boutons. As PV chandelier cells do not contain GAD65 in non-human primate PFC 35 and because their inputs are not enriched with a1-containing GABA A receptors, 41 our approach excluded PV chandelier cell boutons. Several important aspects of the experimental and classification design mitigate the limitations of using light microscopy to identify synapses: (1) the use of two presynaptic markers (PV and GAD65) and a postsynaptic marker (GABA A a1 subunit), (2) strict object mask size requirements that were restricted to a biologically relevant range for pre-and postsynaptic structures and (3) strict spatial relationship criteria among the three markers.
Statistics
An analysis of covariance model was performed on each dependent measure using diagnostic group as the main effect and sex, age, race, postmortem interval, pH and storage time as covariates. The only covariate that significantly affected any dependent measure was an effect of postmortem interval on PVBC input density (F (1, 12) ¼ 6.186, P ¼ 0.029).
RESULTS

GAD65 is expressed in PVBC boutons but not in PV chandelier cell boutons
We have previously shown in non-human primate DLPFC that PV chandelier cell boutons exclusively express GAD67, whereas PVBCs express both GAD65 and GAD67. 35 We performed the same analysis in three healthy comparison subjects to determine whether this relationship was conserved in human DLPFC (Figure 3) . Indeed, mean GAD65 fluorescence intensity was 99% lower (t (4) ¼ 12.5, Po0.001) in PV chandelier boutons (11.3 ± 2.5 a.u.) relative to PVBC boutons (1 206.7 ± 165.7 a.u.). Mean GAD67 fluorescence intensity did not differ (t (4) ¼ 1.8, P ¼ 0.15) between PV chandelier boutons (971.8±162.2 a.u.) and PVBC boutons (1 207.3 ± 164.5 a.u.). Thus, as in monkey DLPFC, PVBC boutons in human DLPFC contain both GAD65 and GAD67.
PVBC input density is unchanged in schizophrenia A total of 63 621 and 71 359 triple-labeled PVBC inputs were analyzed in the 10 pairs of comparison and schizophrenia subjects, respectively. The mean density of PVBC inputs did not differ (F (1, 12) ¼ 2.126, P ¼ 0.17) between healthy comparison (12.5/ mm 3 ± 2.2) and schizophrenia (14.1/mm 3 ± 2.4) subjects (Figure 4a ). These data demonstrate that schizophrenia is not associated with a loss of DLPFC PVBC inputs.
Relative PV protein levels are lower in PVBC inputs in schizophrenia We next quantified GAD65, PV and GABA A receptor a1 subunit fluorescence intensities within PVBC inputs to assess measures that may affect PVBC synaptic strength.
Mean PV fluorescence intensity was 23% lower (Figure 4b ; F (1, 12) ¼ 7.531, P ¼ 0.018) in PVBC boutons of schizophrenia subjects (4 794.2 a.u. ± 993.7) relative to healthy comparison subjects (6 212.3 a.u. ± 1397.1). GAD65 and GABA A a1 mean fluorescence intensities did not differ (Figure 4b; all F (1, 12) o0.87, P40.36) between healthy comparison and schizophrenia subjects.
DISCUSSION
To date, methodological obstacles have precluded the quantification of disease-related effects on synaptic inputs from an identified neuronal population in human postmortem tissue. Using an approach recently developed in our laboratory, we conducted the first quantitative examination of PVBC inputs in schizophrenia subjects. Our findings demonstrate that the density of PVBC inputs in the DLPFC is unchanged in schizophrenia, but that PVBC axonal bouton levels of PV protein are lower. These findings are supported by previous studies showing no deficit in PV cell number but lower PV mRNA expression per neuron in the DLPFC of schizophrenia subjects (reviewed in Lewis et al. 20 ). The current findings also clarify the interpretation of a single-label immunoperoxidase study, which found a lower density of PVimmunoreactive puncta, presumed axonal boutons, in the middle layers of DLPFC area 9 in schizophrenia subjects. 23 This observation has been interpreted as possibly reflecting fewer PV-containing projections from the mediodorsal thalamic nucleus 23 and/or fewer PVBC boutons in the DLPFC of schizophrenia subjects. 20 However, the results of this study show that this finding likely reflects the reduction in PV protein within PVBCs to levels below those detectable by traditional immunoperoxidase methods. 42 Thus, in concert with prior studies, our findings strongly suggest that neither the number nor axonal morphology of PVBCs are altered in schizophrenia, but that reduced PV mRNA expression results in lower levels of PV protein within PVBC axon terminals.
Prior studies have also reported lower GAD67 mRNA in PV cells 22 and lower GAD67 protein in putative PVBC boutons, 26 suggesting that PVBC inputs have lower levels of both PV and GAD67 proteins. Whether GAD67 is lower in the PVBC inputs examined in the present study could not be determined. However, taken together, the available data suggest that GABA synthesis and calcium buffering within PVBC axon terminals is significantly lower in schizophrenia. This combination of lower protein levels with preserved PVBC synaptic density has important implications for determining whether these alterations might reflect a cause or consequence of DLPFC dysfunction in schizophrenia.
The combination of a normal density of PVBC inputs and lower PV and GAD67 26 protein levels per bouton, but no compensatory upregulation of GAD65 or postsynaptic a1-containing GABA A receptors, could reflect either of two possible upstream events. Schizophrenia is thought to be a disorder of neurodevelopment, and incomplete maturation of PVBCs may be the underlying cause of lower PV and GAD67. For example, although the number of PVBC inputs reaches adult levels by 3 months of age in monkey DLPFC, the amount of PV in these inputs increases substantially from the perinatal period through late adolescence. 43, 44 Thus, our current findings of a normal density of PVBC inputs but lower levels of PV protein per bouton could reflect a developmental disturbance that occurs after PVBC synapses are established, but before PV reaches adult levels in PVBCs, that is sometime between childhood and late adolescence. Interestingly, in children who will develop schizophrenia later in life, working memory performance appears normal at age seven, and then lags behind the normal rate of improvement. [45] [46] [47] Future confirmation of this time course for the appearance of PVBC disturbances would represent a unique opportunity to utilize preemptive strategies that normalize PVBC maturation.
Alternatively, these findings could reflect molecular consequences of chronic reductions in excitatory drive to layer 3 DLPFC pyramidal cells in schizophrenia. 20 For example, PV 48 and GAD67 49 expression is activity dependent, and PVBCs receive dense excitatory innervation from layer 3 pyramidal cells. 50 DLPFC layer 3 pyramidal cells exhibit several alterations suggestive of decreased excitation in schizophrenia, such as lower dendritic spine density. 51 Together, these data suggest that lower excitation and activity of layer 3 pyramidal cells may preferentially reduce PVBC activation, leading to a downregulation of PV and GAD67 expression.
Whether a cause or consequence, the current findings help to focus the search for appropriate pharmacological targets to ameliorate DLPFC dysfunction in schizophrenia. As the number of PVBC inputs is preserved, modulating their activity represents a viable option to restore DLPFC functioning in schizophrenia as lower PV and GAD67 protein levels within PVBC boutons are likely to contribute to the reduced power of prefrontal gamma oscillations in schizophrenia. 20, 52 For example, a recent computational modeling study reported that decreasing both PV and GABA within PV neurons reduced stimulus-induced gamma band power in a manner similar to that observed in schizophrenia subjects. 52 Thus, lower PV and GAD67 protein within PVBCs may represent a key substrate for impaired gamma oscillations and working memory in schizophrenia subjects, and modulating their expression and/or function within PVBCs represents a potential therapeutic strategy. 
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